These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


536 related items for PubMed ID: 29123382

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Octreotide-modification enhances the delivery and targeting of doxorubicin-loaded liposomes to somatostatin receptors expressing tumor in vitro and in vivo.
    Sun M, Wang Y, Shen J, Xiao Y, Su Z, Ping Q.
    Nanotechnology; 2010 Nov 26; 21(47):475101. PubMed ID: 21030757
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models.
    Chi Y, Yin X, Sun K, Feng S, Liu J, Chen D, Guo C, Wu Z.
    J Control Release; 2017 Sep 10; 261():113-125. PubMed ID: 28666726
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
    Belhadj Z, Ying M, Cao X, Hu X, Zhan C, Wei X, Gao J, Wang X, Yan Z, Lu W.
    J Control Release; 2017 Jun 10; 255():132-141. PubMed ID: 28390902
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Targeted and intracellular triggered delivery of therapeutics to cancer cells and the tumor microenvironment: impact on the treatment of breast cancer.
    Moura V, Lacerda M, Figueiredo P, Corvo ML, Cruz ME, Soares R, de Lima MC, Simões S, Moreira JN.
    Breast Cancer Res Treat; 2012 May 10; 133(1):61-73. PubMed ID: 21805188
    [Abstract] [Full Text] [Related]

  • 17. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
    Yang Y, Yang Y, Xie X, Cai X, Zhang H, Gong W, Wang Z, Mei X.
    Biomaterials; 2014 May 10; 35(14):4368-81. PubMed ID: 24565519
    [Abstract] [Full Text] [Related]

  • 18. Liposomes co-modified with cholesterol anchored cleavable PEG and octaarginines for tumor targeted drug delivery.
    Tang J, Fu H, Kuang Q, Zhang L, Zhang Q, Liu Y, Ran R, Gao H, Zhang Z, He Q.
    J Drug Target; 2014 May 10; 22(4):313-26. PubMed ID: 24404866
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Doxorubicin loaded pH-sensitive micelle targeting acidic extracellular pH of human ovarian A2780 tumor in mice.
    Gao ZG, Lee DH, Kim DI, Bae YH.
    J Drug Target; 2005 Aug 10; 13(7):391-7. PubMed ID: 16308207
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.